Regression of scleromyxedema with topical betamethasone and dimethyl sulfoxide: a 30-month follow-up.
Bonnetblanc
J M
JM
Bedane
C
C
D000287:Administration, Topical; D000368:Aged; D001623:Betamethasone / Q000627:therapeutic use*; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009230:Myxedema / Q000188:drug therapy*; D012074:Remission Induction; D012594:Scleroderma, Localized / Q000188:drug therapy*
D001623:Betamethasone; D004121:Dimethyl Sulfoxide